1.
Kaustubh Bhardwaj, Himanshi Bhardwaj, Amit Tripathi, Latika Tolia, Snigdh Agarwal, Devashish Srivastava, et al. FUTURE CHALLENGES AND EMERGING SAFETY CONCERNS OF GLP-1 RECEPTOR AGONISTS, DUAL INCRETIN AGONISTS, AND SGLT2 INHIBITORS. J Popl Ther Clin Pharmacol [Internet]. 2026 Jun. 16 [cited 2026 Oct. 18];33(2):963-81. Available from: https://www.jptcp.com/index.php/jptcp/article/view/13620